Global Diaphragm Pacing Device Revenue Is Nearly 4041 K USD and The Actual Sales Are About 140 Unit In 2017
Friday, 15 Nov, 2019
A diaphragm pacing system is a lightweight, battery-powered electronic pacing system that electrically stimulates your diaphragm muscles and nerves. This causes your diaphragm to contract so that air is pulled into your lungs. It helps you breathe in a more normal fashion.
In the last several years, global market of Diaphragm Pacing Device developed rapidly, with an average growth rate of 9.69% during 2013 to 2017. In 2017, global revenue of Diaphragm Pacing Device is nearly 4041 K USD; the actual sales are about 140 unit.
The global average price of Diaphragm Pacing Device is in the increasing trend, from 25.4 K USD/Unit in 2013 to 29.1 K USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Diaphragm Pacing Device includes External Diaphragm Pacemaker and diaphragm Pacemaker. The proportion of diaphragm Pacemaker in 2017 is about 97.6% of revenue.
Diaphragm Pacing Device is application in SCI, ALS and Other. The most of Diaphragm Pacing Device is used in SCI, and the market share of that is about 55 % in 2017.
North America is the largest consumption place, with a consumption market share nearly 48.8% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 33.3% in 2017.
Market competition is intense. Avery Biomedical Devices and Synapse Biomedical are the leaders of the industry, and have been formed in the monopoly position in the industry.